Administrative Core

行政核心

基本信息

  • 批准号:
    10774552
  • 负责人:
  • 金额:
    $ 265.65万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-30 至 2028-08-31
  • 项目状态:
    未结题

项目摘要

ABSTRACT: Administrative Core The National Dementia Workforce Study (NDWS) will be launched by a national team of experts in clinical care of persons living with dementia, survey research, and health workforce research. The goal of the NDWS data infrastructure is to allow researchers and policymakers to ask and answer scientific questions to help build the workforce of clinicians and other professional care providers required by the growing population of persons living with dementia in the U.S. The core of NDWS will be four surveys that reflect key elements of the professional dementia care workforce in the U.S.: Community Clinicians, Nursing Home Staff, Assisted Living Staff, and Home Care Staff. In addition to these surveys, the NDWS team will develop a variety of additional data sources that can be linked with the surveys in order to maximize the scientific potential of the surveys. The Administrative Core will be responsible for the overall organization, management, decision-making, and communication for NDWS, including coordinating knowledge dissemination activities to ensure that the research community is aware of the tremendous new data infrastructure that will be created by this project. The Administrative Core will provide oversight and consultation to each of the Cores to ensure that scientific objectives are met and that there is optimal utilization of resources. Specifically, the Administrative Core will: 1) Administer, manage, and integrate all elements of the NDWS cooperative team; 2) Coordinate and integrate all elements of the NDWS data products; 3) Develop and disseminate data products, guidance materials, and training opportunities to ensure full and timely use of the four NDWS surveys and available linked data; and 4) Coordinate stakeholder engagement—including persons living with dementia, their caregivers, dementia workforce providers, and institutional leaders—across the Cores to maximize the utility and potential impact of NDWS.
摘要:行政核心

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DONOVAN T MAUST其他文献

DONOVAN T MAUST的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DONOVAN T MAUST', 18)}}的其他基金

The Impact of Alzheimer’s Disease and Related Dementias on Nursing Home Care and Quality for Persons with Serious Mental Illness
阿尔茨海默病和相关痴呆症对严重精神疾病患者的疗养院护理和质量的影响
  • 批准号:
    10803736
  • 财政年份:
    2023
  • 资助金额:
    $ 265.65万
  • 项目类别:
The National Dementia Workforce Study
国家痴呆症劳动力研究
  • 批准号:
    10774551
  • 财政年份:
    2023
  • 资助金额:
    $ 265.65万
  • 项目类别:
Prescribing without a guide: A national study of psychotropic and opioid polypharmacy among persons living with dementia
在没有指导的情况下开药:一项关于痴呆症患者精神药物和阿片类药物复方用药的全国研究
  • 批准号:
    10337351
  • 财政年份:
    2022
  • 资助金额:
    $ 265.65万
  • 项目类别:
Prescribing without a guide: A national study of psychotropic and opioid polypharmacy among persons living with dementia
在没有指导的情况下开药:一项关于痴呆症患者精神药物和阿片类药物复方用药的全国研究
  • 批准号:
    10608057
  • 财政年份:
    2022
  • 资助金额:
    $ 265.65万
  • 项目类别:
Addressing inappropriate benzodiazepine prescribing among older Veterans
解决老年退伍军人中不当使用苯二氮卓类药物的问题
  • 批准号:
    9653887
  • 财政年份:
    2018
  • 资助金额:
    $ 265.65万
  • 项目类别:
Addressing inappropriate benzodiazepine prescribing among older Veterans
解决老年退伍军人中不当使用苯二氮卓类药物的问题
  • 批准号:
    10186531
  • 财政年份:
    2018
  • 资助金额:
    $ 265.65万
  • 项目类别:
Patient, Caregiver, and Regional Drivers of Potentially Inappropriate Medical Care for Dementia: Building the Foundation for State Dementia Policy
痴呆症医疗护理可能不适当的患者、护理人员和地区驱动因素:为国家痴呆症政策奠定基础
  • 批准号:
    10090545
  • 财政年份:
    2018
  • 资助金额:
    $ 265.65万
  • 项目类别:
Preventable Hospitalization in Dementia: The Impact of Neuropsychiatric Symptoms
痴呆症可预防的住院治疗:神经精神症状的影响
  • 批准号:
    8769634
  • 财政年份:
    2014
  • 资助金额:
    $ 265.65万
  • 项目类别:

相似国自然基金

新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 批准年份:
    2010
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 批准年份:
    2010
  • 资助金额:
    26.0 万元
  • 项目类别:
    地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
  • 批准号:
    30960334
  • 批准年份:
    2009
  • 资助金额:
    22.0 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
  • 批准号:
    10657993
  • 财政年份:
    2023
  • 资助金额:
    $ 265.65万
  • 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
  • 批准号:
    10381163
  • 财政年份:
    2022
  • 资助金额:
    $ 265.65万
  • 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
  • 批准号:
    10531959
  • 财政年份:
    2022
  • 资助金额:
    $ 265.65万
  • 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
  • 批准号:
    10700991
  • 财政年份:
    2022
  • 资助金额:
    $ 265.65万
  • 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
  • 批准号:
    10518582
  • 财政年份:
    2022
  • 资助金额:
    $ 265.65万
  • 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
  • 批准号:
    10672973
  • 财政年份:
    2022
  • 资助金额:
    $ 265.65万
  • 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
  • 批准号:
    10585925
  • 财政年份:
    2022
  • 资助金额:
    $ 265.65万
  • 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
  • 批准号:
    10180000
  • 财政年份:
    2021
  • 资助金额:
    $ 265.65万
  • 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
  • 批准号:
    10049426
  • 财政年份:
    2021
  • 资助金额:
    $ 265.65万
  • 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
  • 批准号:
    10295809
  • 财政年份:
    2021
  • 资助金额:
    $ 265.65万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了